Multistage Carcinogenesis: Cell and Animal Models

Molly Kulesz-Martin, X. Ouyang, A. Barling, J. R. Gallegos, Yuangang Liu, T. Medler

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Carcinogenesis is a multistage process that involves numerous etiologies that work at different stages of tumor development. Our ability to dissect oncogenic events is largely dependent on the availability of model systems that recapitulate human carcinogenesis at both the pathological and molecular levels. With progress in molecular and cell biology, studies with cell model systems have produced many important conceptual advances for our understanding of the mechanism of carcinogenesis. In parallel, animal models provide the tissue and the systemic contexts of carcinogenesis and serve to validate molecular predictions and targeting opportunities in cancer prevention and treatment. With the development of genetically engineered mouse models, the functional consequences and tissue dynamics of genetic alterations can be defined at discrete stages of carcinogenesis. The cooperative models that bridge cell culture techniques and corresponding animal models offer simple and quantitative approaches to evaluate the oncogenic potential of carcinogens (chemical, viral, and physical agents), immunity, as well as the roles of discrete candidate cancer genes in carcinogenesis. The choice of a model is of importance and should take into account the cell/tissue type of origin, the complexity of carcinogenesis, the variety of carcinogen and therapeutic reagents to be tested, and the relevance to human cancer.

Original languageEnglish (US)
Title of host publicationCarcinogenesis
PublisherElsevier Inc.
Pages11-35
Number of pages25
Volume7-15
ISBN (Electronic)9780081006122
ISBN (Print)9780081006016
DOIs
StatePublished - Dec 15 2017

Fingerprint

Carcinogenesis
Animal Models
Carcinogens
Neoplasms
Neoplasm Genes
Cell Biology
Molecular Biology
Immunity
Cell Culture Techniques
Therapeutics

Keywords

  • Animal model
  • Carcinogenesis
  • Cell model
  • Epithelial transformation
  • Hallmarks of cancer
  • Hepatocarcinogenesis
  • Initiation
  • Malignant conversion
  • Oncogenic pathways
  • P53
  • RAS
  • Squamous cell carcinoma
  • Tumor progression
  • Tumor promotion
  • Tumorigenesis
  • Two-stage carcinogenesis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kulesz-Martin, M., Ouyang, X., Barling, A., Gallegos, J. R., Liu, Y., & Medler, T. (2017). Multistage Carcinogenesis: Cell and Animal Models. In Carcinogenesis (Vol. 7-15, pp. 11-35). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-801238-3.02218-2

Multistage Carcinogenesis : Cell and Animal Models. / Kulesz-Martin, Molly; Ouyang, X.; Barling, A.; Gallegos, J. R.; Liu, Yuangang; Medler, T.

Carcinogenesis. Vol. 7-15 Elsevier Inc., 2017. p. 11-35.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kulesz-Martin, M, Ouyang, X, Barling, A, Gallegos, JR, Liu, Y & Medler, T 2017, Multistage Carcinogenesis: Cell and Animal Models. in Carcinogenesis. vol. 7-15, Elsevier Inc., pp. 11-35. https://doi.org/10.1016/B978-0-12-801238-3.02218-2
Kulesz-Martin M, Ouyang X, Barling A, Gallegos JR, Liu Y, Medler T. Multistage Carcinogenesis: Cell and Animal Models. In Carcinogenesis. Vol. 7-15. Elsevier Inc. 2017. p. 11-35 https://doi.org/10.1016/B978-0-12-801238-3.02218-2
Kulesz-Martin, Molly ; Ouyang, X. ; Barling, A. ; Gallegos, J. R. ; Liu, Yuangang ; Medler, T. / Multistage Carcinogenesis : Cell and Animal Models. Carcinogenesis. Vol. 7-15 Elsevier Inc., 2017. pp. 11-35
@inbook{7a23f0ab2f8c4f278337f8c45950670d,
title = "Multistage Carcinogenesis: Cell and Animal Models",
abstract = "Carcinogenesis is a multistage process that involves numerous etiologies that work at different stages of tumor development. Our ability to dissect oncogenic events is largely dependent on the availability of model systems that recapitulate human carcinogenesis at both the pathological and molecular levels. With progress in molecular and cell biology, studies with cell model systems have produced many important conceptual advances for our understanding of the mechanism of carcinogenesis. In parallel, animal models provide the tissue and the systemic contexts of carcinogenesis and serve to validate molecular predictions and targeting opportunities in cancer prevention and treatment. With the development of genetically engineered mouse models, the functional consequences and tissue dynamics of genetic alterations can be defined at discrete stages of carcinogenesis. The cooperative models that bridge cell culture techniques and corresponding animal models offer simple and quantitative approaches to evaluate the oncogenic potential of carcinogens (chemical, viral, and physical agents), immunity, as well as the roles of discrete candidate cancer genes in carcinogenesis. The choice of a model is of importance and should take into account the cell/tissue type of origin, the complexity of carcinogenesis, the variety of carcinogen and therapeutic reagents to be tested, and the relevance to human cancer.",
keywords = "Animal model, Carcinogenesis, Cell model, Epithelial transformation, Hallmarks of cancer, Hepatocarcinogenesis, Initiation, Malignant conversion, Oncogenic pathways, P53, RAS, Squamous cell carcinoma, Tumor progression, Tumor promotion, Tumorigenesis, Two-stage carcinogenesis",
author = "Molly Kulesz-Martin and X. Ouyang and A. Barling and Gallegos, {J. R.} and Yuangang Liu and T. Medler",
year = "2017",
month = "12",
day = "15",
doi = "10.1016/B978-0-12-801238-3.02218-2",
language = "English (US)",
isbn = "9780081006016",
volume = "7-15",
pages = "11--35",
booktitle = "Carcinogenesis",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Multistage Carcinogenesis

T2 - Cell and Animal Models

AU - Kulesz-Martin, Molly

AU - Ouyang, X.

AU - Barling, A.

AU - Gallegos, J. R.

AU - Liu, Yuangang

AU - Medler, T.

PY - 2017/12/15

Y1 - 2017/12/15

N2 - Carcinogenesis is a multistage process that involves numerous etiologies that work at different stages of tumor development. Our ability to dissect oncogenic events is largely dependent on the availability of model systems that recapitulate human carcinogenesis at both the pathological and molecular levels. With progress in molecular and cell biology, studies with cell model systems have produced many important conceptual advances for our understanding of the mechanism of carcinogenesis. In parallel, animal models provide the tissue and the systemic contexts of carcinogenesis and serve to validate molecular predictions and targeting opportunities in cancer prevention and treatment. With the development of genetically engineered mouse models, the functional consequences and tissue dynamics of genetic alterations can be defined at discrete stages of carcinogenesis. The cooperative models that bridge cell culture techniques and corresponding animal models offer simple and quantitative approaches to evaluate the oncogenic potential of carcinogens (chemical, viral, and physical agents), immunity, as well as the roles of discrete candidate cancer genes in carcinogenesis. The choice of a model is of importance and should take into account the cell/tissue type of origin, the complexity of carcinogenesis, the variety of carcinogen and therapeutic reagents to be tested, and the relevance to human cancer.

AB - Carcinogenesis is a multistage process that involves numerous etiologies that work at different stages of tumor development. Our ability to dissect oncogenic events is largely dependent on the availability of model systems that recapitulate human carcinogenesis at both the pathological and molecular levels. With progress in molecular and cell biology, studies with cell model systems have produced many important conceptual advances for our understanding of the mechanism of carcinogenesis. In parallel, animal models provide the tissue and the systemic contexts of carcinogenesis and serve to validate molecular predictions and targeting opportunities in cancer prevention and treatment. With the development of genetically engineered mouse models, the functional consequences and tissue dynamics of genetic alterations can be defined at discrete stages of carcinogenesis. The cooperative models that bridge cell culture techniques and corresponding animal models offer simple and quantitative approaches to evaluate the oncogenic potential of carcinogens (chemical, viral, and physical agents), immunity, as well as the roles of discrete candidate cancer genes in carcinogenesis. The choice of a model is of importance and should take into account the cell/tissue type of origin, the complexity of carcinogenesis, the variety of carcinogen and therapeutic reagents to be tested, and the relevance to human cancer.

KW - Animal model

KW - Carcinogenesis

KW - Cell model

KW - Epithelial transformation

KW - Hallmarks of cancer

KW - Hepatocarcinogenesis

KW - Initiation

KW - Malignant conversion

KW - Oncogenic pathways

KW - P53

KW - RAS

KW - Squamous cell carcinoma

KW - Tumor progression

KW - Tumor promotion

KW - Tumorigenesis

KW - Two-stage carcinogenesis

UR - http://www.scopus.com/inward/record.url?scp=85043345875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043345875&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801238-3.02218-2

DO - 10.1016/B978-0-12-801238-3.02218-2

M3 - Chapter

AN - SCOPUS:85043345875

SN - 9780081006016

VL - 7-15

SP - 11

EP - 35

BT - Carcinogenesis

PB - Elsevier Inc.

ER -